Regeneron Pharmaceuticals CEO Boasts Recently Approved Cholesterol-Lowering Drug

By: via Benzinga
Regeneron Pharmaceuticals Inc (NASDAQ: REGN)'s cholesterol-lowering drug Praluent recently received approval by the U.S. Food and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.